Nicoderm cq side effects by duration, gender and age - a phase IV clinical study of FDA data
Summary:
Side effects are reported by people who take Nicoderm cq. Common side effects include application site erythema, drug ineffective among females, and application site erythema, drug ineffective among males.
The phase IV clinical study is created by eHealthMe based on 18,008 reports from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
What are phase IV trials?
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
18,008 people who take Nicoderm Cq and have side effects are studied.
What is Nicoderm Cq?
Nicoderm cq has active ingredients of nicotine. It is used in quit smoking. Currently, eHealthMe is studying from 18,125 Nicoderm cq users.
Number of Nicoderm cq reports submitted per year:
Nicoderm cq side effects by time on the drug *:
Nicoderm cq side effects by gender *:
Nicoderm cq side effects by age *:
* Approximation only. Some reports may have incomplete information.
Do you take Nicoderm cq?
Personalize this study to your gender and ageHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How the study uses the data?
The study is based on nicotine (the active ingredients of Nicoderm cq) and Nicoderm cq (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered.
Related studies
Alternative drugs to, pros and cons of Nicoderm cq:
- Nicoderm cq (18,125 reports)
Common Nicoderm cq side effects:
- Drug ineffective: 2,491 reports
- Dizziness: 1,056 reports
All Nicoderm cq side effects from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zWho is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Yasmin and Leukopenia - 3 seconds ago
- Onglyza and Avandia drug interaction - 6 seconds ago
- Latuda and Loss Of Employment - 9 seconds ago
- Atropine Sulfate and Pneumonia - 11 seconds ago
- Anastrozole and Cardiac Failure Acute - 18 seconds ago
- Trazodone Hydrochloride and Laryngeal Nerve Damage - 23 seconds ago
- Minoxidil and Protein - Urine - 24 seconds ago
- Simvastatin and Pulmonary Toxicity - 40 seconds ago
- Hydroxyzine and Nascobal drug interaction - 40 seconds ago
- Soma and Nasonex drug interaction - 48 seconds ago